Eisai is a human health care company that provides products and services to its patients and their families under any healthcare system.
Eisai is a human health care company that provides products and services to its patients and their families under any healthcare system. Eisai specializes in the integrated pharmaceutical business that operates in business groups it focuses on oncology and neurology, dementia-related diseases and neurodegenerative diseases.The company was founded in 1941 and headquartered in Tokyo, Japan.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 27, 2022
Ractigen Therapeutics
|
Series A | $30M | Health Care | — |